NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Jeet will be a trusted partner in cardiovascular care
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
However, PAT growth will be lower than operating profit growth mainly due to brand amortization expenditure on account of acquisition.
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
GenWorks has scaled up its e-commerce platform in terms of building traffic
Augnito’s AI comprehends all English accents with 99% accuracy
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
Subscribe To Our Newsletter & Stay Updated
